-
1 Comment
Prim, S.A is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Prim, S.A's total revenue sank by 11.5% to $37M since the same quarter in the previous year.
Its net income has dropped by 39.7% to $3M since the same quarter in the previous year.
Based on the above factors, Prim, S.A gets an overall score of 2/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | ES0170884417 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 165M |
|---|---|
| PE Ratio | 14.97 |
| Target Price | None |
| Beta | 0.49 |
| Dividend Yield | 2.3% |
Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, ORTHOPrim, PRIMcare, respira PLUS, airMed, airtex, AirTex breathable, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. The company was founded in 1870 and is headquartered in Móstoles, Spain.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 5P1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
